跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
連結會在新分頁中開啟
English
中文
在 臺北醫學大學 搜尋內容
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
查看斯高帕斯 (Scopus) 概要
王 智揚
副教授
,
癌症生物學與藥物研發博士學位學程
成員
,
臺北醫學大學癌症轉譯研究中心
https://orcid.org/0000-0002-4137-5074
電子郵件
chihyang
tmu.edu
tw
No. 250 Wu-Xing Street, Taipei 11031
h-index
3951
引文
35
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2012
2026
每年研究成果
概覽
指紋
網路
專案
(9)
研究成果
(109)
類似的個人檔案
(6)
指紋
查看啟用 Chih-Yang Wang 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Biochemistry, Genetics and Molecular Biology
Multigene Family
100%
Gene Signature
48%
Gene Expression
47%
Cancer Cell
45%
Cell Cycle
41%
SEQUEST
31%
Overall Survival
29%
Proteasome
27%
Metabolic Pathway
23%
Epidermal Growth Factor Receptor
21%
Signal Transduction
21%
Cell Proliferation
20%
Messenger RNA
19%
Estrogen Receptor
19%
Carcinogenesis
18%
Eicosanoid Receptor
18%
Transcription
18%
Immunocompetent Cell
17%
Argininosuccinate Lyase
17%
Genetics
16%
Biological Phenomena and Functions Concerning the Entire Organism
16%
Phosphotransferase
15%
Kinase
15%
down Regulation
14%
Oncogene
14%
RNA Sequence
14%
Survival Rate
14%
Microarrays
14%
Transcriptomics
14%
Small Hairpin RNA
13%
Gene Expression Profiling
13%
MicroRNA
13%
Autophagy
13%
Tumor Progression
12%
Immune Response
12%
Integrin
12%
Mouse
12%
Myeloid
11%
Macrophage
11%
RNA
11%
Cell Growth
11%
Protein Family
11%
CD90
11%
Voltage Gated Calcium Channel
11%
Long Non-Coding RNA
11%
ATPase
11%
Integrin
11%
Cell Migration
11%
Mouse Model
10%
B Cell
10%
Medicine and Dentistry
Breast Cancer
63%
Malignant Neoplasm
59%
Neoplasm
28%
Multigene Family
26%
Gene Expression
21%
Lung Adenocarcinoma
19%
Severe Acute Respiratory Syndrome Coronavirus 2
18%
Hepatocellular Carcinoma
18%
Biological Marker
18%
Carcinogenesis
17%
Infection
16%
microRNA
16%
Macrophage
15%
Cancer Therapy
15%
Therapy Effect
14%
Short Hairpin RNA
13%
Lung Cancer
13%
In Vitro
13%
SARS Coronavirus
12%
Glioblastoma
11%
Cell Cycle
11%
Proteasome
11%
Stomach Cancer
11%
Integrin
11%
Signal Transduction
10%
Cell Migration
10%
Cancer Cell
9%
Transcriptomics
8%
Immune Cell Infiltration
8%
Gelatinase B
8%
Epithelial Cell
7%
Tumor Progression
7%
Gene Expression Profiling
7%
Adenocarcinoma
7%
Metastatic Carcinoma
7%
SEQUEST
7%
Cancer Growth
7%
Cancer
7%
Cancer Tissue
7%
Ventricular Hypertrophy
7%
Hepatic Stellate Cell
7%
Recurrent Disease
7%
Prostate Cancer
7%
Colorectal Cancer
6%
Upregulation
6%
Lipid Metabolism
6%
DNA Methylation
6%
The Cancer Genome Atlas
6%
Tumor Necrosis Factor Receptor
6%
Myeloid-Derived Suppressor Cell
6%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
69%
Breast Cancer
44%
Neoplasm
37%
Lung Adenocarcinoma
30%
Biological Marker
25%
SARS Coronavirus
19%
Colorectal Cancer
18%
Lung Cancer
18%
Carcinogenesis
17%
Integrin
17%
Short Hairpin RNA
14%
Infection
14%
Stomach Cancer
13%
Chronic Myeloid Leukemia
12%
Mouse
12%
Thrombospondin 1
11%
Matrix Metalloproteinase
11%
Argininosuccinate Lyase
11%
Acute Myeloid Leukemia
11%
Therapeutic Effect
10%
Western Blot
10%
Arginine
9%
Tumor Growth
9%
Tumor Necrosis Factor
9%
Cancer Growth
9%
CD8 Antigen
9%
Liver Cell Carcinoma
9%
Primary Tumor
9%
Disease
8%
Janus Kinase
8%
Metastasis
8%
Nitric Oxide
8%
Estrogen Receptor Positive Breast Cancer
7%
Liver Cancer
7%
Epidermal Growth Factor Receptor
7%
Heart Ventricle Hypertrophy
7%
Phytochemical
7%
Cancer Model
7%
Receptor
7%
Mouse Model
7%
Combination Therapy
6%
Gelatinase B
6%
Cell Marker
6%
Liver Tumor
6%
Cytokine
6%
Cyclin A2
6%
Metastatic Breast Cancer
6%
Prostate Cancer
6%
Phosphatidylinositol 3 Kinase
6%
DNA Vaccine
6%
